Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Evofem Biosciences, Inc. (EVFM) had Earnings per Share (EPS) (Basic) of $-0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$4.95M |
|
$-1.68M |
|
$0.91M |
|
$4.05M |
|
$4.00M |
|
$0.95M |
|
$-2.52M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$-1.57M |
|
$0.95M |
|
$1.07M |
|
119.58M |
|
119.58M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.01 |
$-0.01 |
|
| Balance Sheet Financials | |
$7.92M |
|
$0.42M |
|
$5.89M |
|
$13.81M |
|
$78.19M |
|
-- |
|
$5.79M |
|
$83.98M |
|
$-75.07M |
|
$-75.41M |
|
$-70.17M |
|
123.96M |
|
| Cash Flow Statement Financials | |
$-2.02M |
|
$-0.06M |
|
$2.18M |
|
$0.74M |
|
$0.84M |
|
$0.10M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.10 |
|
-- |
|
-- |
|
-- |
|
-0.74 |
|
81.72% |
|
19.20% |
|
19.20% |
|
-- |
|
-31.76% |
|
-33.93% |
|
$-2.08M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
0.54 |
|
1.12 |
|
80.60 |
|
2.09% |
|
2.08% |
|
-11.36% |
|
2.24% |
|
$-0.57 |
|
$-0.02 |
|
$-0.02 |
|